Detection of a SARS-CoV-2 variant of concern in South Africa.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
21
12
2020
accepted:
26
02
2021
pubmed:
11
3
2021
medline:
21
4
2021
entrez:
10
3
2021
Statut:
ppublish
Résumé
Continued uncontrolled transmission of SARS-CoV-2 in many parts of the world is creating conditions for substantial evolutionary changes to the virus
Identifiants
pubmed: 33690265
doi: 10.1038/s41586-021-03402-9
pii: 10.1038/s41586-021-03402-9
doi:
Substances chimiques
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
438-443Commentaires et corrections
Type : CommentIn
Références
Fontanet, A. et al. SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet 397, 952–954 (2021).
Mascola, J. R., Graham, B. S. & Fauci, A. S. SARS-CoV-2 viral variants—tackling a moving target. J. Am. Med. Assoc. https://doi.org/10.1001/jama.2021.2088 (2021).
Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182, 1295–1310 (2020).
doi: 10.1016/j.cell.2020.08.012
Greaney, A. J. et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe 29, 463–476.e6 (2021).
Greaney, A. J. et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 29, 44–57 (2021).
doi: 10.1016/j.chom.2020.11.007
Pearson, C. A.B. et al. Estimates of severity and transmissibility of novel South Africa SARS-CoV-2 variant 501Y.V2. Preprint at https://cmmid.github.io/topics/covid19/sa-novel-variant.html (2021).
Cele, S. et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature https://doi.org/10.1038/s41586-021-03471-w (2021).
Wibmer, C. K. et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat. Med. https://doi.org/10.1038/s41591-021-01285-x (2021).
Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121–4123 (2018).
doi: 10.1093/bioinformatics/bty407
Shu, Y. & McCauley, J. GISAID: global initiative on sharing all influenza data – from vision to reality. Euro Surveill. 22, 30494 (2017).
doi: 10.2807/1560-7917.ES.2017.22.13.30494
Korber B. et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 182, 812–827 (2020).
doi: 10.1016/j.cell.2020.06.043
Plante, J. A. et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature https://doi.org/10.1038/s41586-020-2895-3 (2020).
Yurkovetskiy, L. et al. Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell 183, 739–751 (2020).
doi: 10.1016/j.cell.2020.09.032
Volz, E. et al. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell 184, 64–75 (2021).
doi: 10.1016/j.cell.2020.11.020
Thomson, E. C. et al. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell 184, 1171–1187.e20 (2021).
Bradshaw, D., Laubscher, R., Dorrington, R., Groenewald, P. & Moultrie, T. Report on Weekly Deaths in South Africa: 1 January – 8 December 2020 (Week 49) (Burden of Disease Research Unit, South African Medical Research Council, 2020).
Giandhari, J. et al. Early transmission of SARS-CoV-2 in South Africa: an epidemiological and phylogenetic report. Int. J. Infect. Dis. 103, 234–241 (2021).
doi: 10.1016/j.ijid.2020.11.128
Tegally, H. et al. Sixteen novel lineages of SARS-CoV-2 in South Africa. Nat. Med. 27, 440–446 (2021).
Blumberg, L. & Frean, J. COVID-19 second wave in South Africa. National Institute of Communicable Diseases https://www.nicd.ac.za/covid-19-second-wave-in-south-africa (2020).
Msomi, N., Mlisana, K. & de Oliveira, T. A genomics network established to respond rapidly to public health threats in South Africa. Lancet Microbe 1, e229–e230 (2020).
doi: 10.1016/S2666-5247(20)30116-6
Rambaut, A. et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563 (2020).
Volz, E. et al. Transmission of SARS-CoV-2 lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. Preprint at https://doi.org/10.1101/2020.12.30.20249034 (2021).
Gu, H. et al. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science 369, 1603–1607 (2020).
doi: 10.1126/science.abc4730
Nelson, G. et al. Molecular dynamic simulation reveals E484K mutation enhances spike RBD–ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant. Preprint at https://doi.org/10.1101/2021.01.13.426558 (2021).
Zahradník J. et al. SARS-CoV-2 RBD in vitro evolution follows contagious mutation spread, yet generates an able infection inhibitor. Preprint at https://doi.org/10.1101/2021.01.06.425392 (2021).
Hsiao, M. et al. SARS-CoV-2 seroprevalence in the Cape Town metropolitan sub-districts after the peak of infections. NICD COVID-19 Special Public Health Surveill. Bull. 18, 1–9 (2020).
Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183, 1024–1042 (2020).
doi: 10.1016/j.cell.2020.09.037
Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682–687 (2020).
doi: 10.1038/s41586-020-2852-1
Baum, A. et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science 369, 1014–1018 (2020).
doi: 10.1126/science.abd0831
Liu, Z. et al. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe 29, 477–488.e4 (2021).
Weisblum, Y. et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife 9, e61312 (2020).
doi: 10.7554/eLife.61312
Chi, X. et al. A neutralizing human antibody binds to the N-terminal domain of the spike protein of SARS-CoV-2. Science 369, 650–655 (2020).
doi: 10.1126/science.abc6952
McCallum, M. et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell https://doi.org/10.1016/j.cell.2021.03.028 (2021).
Choi, B. et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. 383, 2291–2293 (2020).
doi: 10.1056/NEJMc2031364
Avanzato, V. A. et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 183, 1901–1912 (2020).
doi: 10.1016/j.cell.2020.10.049
Kemp, S. A. et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature https://doi.org/10.1038/s41586-021-03291-y (2021).
Karim, F. et al. HIV infection alters SARS-CoV-2 responsive immune parameters but not clinical outcomes in COVID-19 disease. Preprint at https://doi.org/10.1101/2020.11.23.20236828 (2020).
Marivate, V. & Combrink, H. M. Use of available data to inform the COVID-19 outbreak in South Africa: a case study. Data Sci. J. 19, 19 (2020).
doi: 10.5334/dsj-2020-019
Marivate, V. et al. Coronavirus disease (COVID-19) case data – South Africa https://zenodo.org/record/3732419#.YBXzFegzZPY (2020).
Huisman, J. S. et al. Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2. Preprint at https://doi.org/10.1101/2020.11.26.20239368 (2020).
Quick, J. nCoV-2019 sequencing protocol v3 (LoCost) V.3. protocols.io https://www.protocols.io/view/ncov-2019-sequencing-protocol-v3-locost-bh42j8ye (2020).
Giandhari, J. et al. NEBnext library construction and sequencing for SARS-CoV-2: adapting COVID-19 ARTIC protocol. protocol.io https://www.protocols.io/view/nebnext-library-construction-and-sequencing-for-sa-bhu2j6ye (2020).
Pillay, S. et al. Whole genome sequencing of SARS-CoV-2: adapting Illumina protocols for quick and accurate outbreak investigation during a pandemic. Genes 11, 949 (2020).
doi: 10.3390/genes11080949
Cleemput, S. et al. Genome detective coronavirus typing tool for rapid identification and characterization of novel coronavirus genomes. Bioinformatics 36, 3552–3555 (2020).
doi: 10.1093/bioinformatics/btaa145
Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094–3100 (2018).
doi: 10.1093/bioinformatics/bty191
McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
doi: 10.1101/gr.107524.110
Wilm, A. et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 40, 11189–11201 (2012).
doi: 10.1093/nar/gks918
Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 (2013).
doi: 10.1093/molbev/mst010
Nguyen, L. T., Schmidt, H. A., von Haeseler, A. & Minh, B. Q. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 32, 268–274 (2015).
doi: 10.1093/molbev/msu300
Griffiths, R. C. & Tavaré, S. Sampling theory for neutral alleles in a varying environment. Phil. Trans. R. Soc. Lond. B 344, 403–410 (1994).
doi: 10.1098/rstb.1994.0079
Rambaut, A., Drummond, A. J., Xie, D., Baele, G. & Suchard, M. A. Posterior summarization in Bayesian phylogenetics using Tracer 1.7. Syst. Biol. 67, 901–904 (2018).
doi: 10.1093/sysbio/syy032
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer 2016).
Yu, G., Smith, D. K., Zhu, H., Guan, Y. & Lam, T. T. Y. ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol. Evol. 8, 28–36 (2017).
doi: 10.1111/2041-210X.12628
Lemey, P., Rambaut, A., Welch, J. J. & Suchard, M. A. Phylogeography takes a relaxed random walk in continuous space and time. Mol. Biol. Evol. 27, 1877–1885 (2010).
doi: 10.1093/molbev/msq067
McLaren, Z. M., Ardington, C. & Leibbrandt, M. Distance decay and persistent health care disparities in South Africa. BMC Health Serv. Res. 14, 541 (2014).
doi: 10.1186/s12913-014-0541-1
Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 5, 1403–1407 (2020).
doi: 10.1038/s41564-020-0770-5
Murrell, B. et al. Detecting individual sites subject to episodic diversifying selection. PLoS Genet. 8, e1002764 (2012).
doi: 10.1371/journal.pgen.1002764
Kosakovsky Pond, S. L. & Frost, S. D. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol. Biol. Evol. 22, 1208–1222 (2005).
doi: 10.1093/molbev/msi105
Benton, D. J. et al. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature 588, 327–330 (2020).
doi: 10.1038/s41586-020-2772-0